Venus Pipes IPO subscribed 2.37 times on first day of offer The initial public offer of Venus Pipes and Tubes got fully subscribed within the first few hours of opening on Wednesday. It closed with 2.37 times subscription on the first day. The category meant for Retail Individual Investors (RIIs) received 4.10 times subscription, while the portion for non-institutional investors got subscribed fully and Qualified Institutional Buyers (QIBs) 36 per cent. Proceeds from the issue will be used for financing the project cost towards capacity expansion and backward integration for manufacturing of hollow pipes, to meet working capital requirements and for general corporate purposes. The Gujarat-based company is a growing stainless-steel pipes and tubes manufacturer and exporter in India.The company, under the brand name Venus, supplies its products for applications in diverse sectors, including chemicals, engineering, fertilizers, pharmaceuticals, power, food processing, paper and oil and gas. The equity shares of the company are proposed to be listed on BSE and NSE.SMC Capitals is the manager to the offer.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.